Harvard Health Content API

The FDA has granted accelerated approval to the first new drug in nearly two decades for Alzheimer’s disease. But there are potential side effects, and results of studies of this drug have been mixed. It is not yet known whether the drug truly works, or how effective it will be, so the approval is contingent on the drug’s maker conducting further studies over the next several years.

Prediabetes often precedes the development of type 2 diabetes, and in young and middle-aged people it’s important to identify prediabetes because it may be possible to prevent or delay the development of diabetes. Researchers wanted to know if the implications of being diagnosed with prediabetes are similar for older adults.